Baker Bros Ups Its BCYC Stake to 22.9%

Baker Bros Advisors, renowned for their biotech expertise, increased their stake in Bicycle Therapeutics $BCYC from 19.76% to 22.90%, as disclosed in a 13D filing. 

This signals strong confidence in the company's prospects, likely tied to its innovative "Bicycles" platform for developing novel therapies. 

Given the Bakers' track record, their investment is a notable endorsement of Bicycle Therapeutics' potential. 

In essence, when the Bakers buy, biotech investors pay attention.

Here’s The Hot Corner, with data from December 17, 2024:

Two notable insider purchases were disclosed via Form 4 filings in the energy sector:

• PBF Energy Inc $PBF: Control Empresarial de Capitales SA reported a purchase, adding $5,357,162 to its current position.
• Diamondback Energy $FANG: Director Steven West also disclosed buying shares for $975,960.

Last but not least, congressman Jonathan Jackson revealed the acquisition of Church & Dwight Co $CHD and Amazon $AMZN.